Drug-Coated Balloons Global Market Report 2024

Description

“Drug-Coated Balloons Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug-coated balloons market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug-coated balloons? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The drug-coated balloons market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Product: Drug-Coated Balloons For Peripheral Artery Disease; Drug-Coated Balloons For Coronary Artery Disease; Drug-Coated Balloons For Other Indications
2) By Drug Type: Paclitaxel; Sirolimus
3) By End User: Hospitals; Cardiac Catheterization Labs; Ambulatory Surgical Centers
Companies Mentioned: Acotec Scientific AG; AR Baltic Medical AB; B. Braun Melsungen AG; Becton Dickinson and Company; Biosensors International Group Ltd
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

A drug-coated balloon (DCB) is a medical device employed in the intervention of narrowed or obstructed blood vessels, particularly in interventional cardiology and interventional radiology. Its design facilitates the direct delivery of medication to the site of vascular disease while concurrently performing angioplasty.

The primary categories of products encompassed within drug-coated balloons include those tailored for peripheral artery disease, coronary artery disease, and other indications. Drug-coated balloons (DCBs) for peripheral artery disease are a specific type of medical device utilized in addressing peripheral artery disease (PAD). PAD is characterized by the narrowing or blockage of blood vessels outside the heart or in the lower extremities. Various drug types, such as paclitaxel and sirolimus, are employed, and the end-users encompass hospitals, cardiac catheterization labs, and ambulatory surgical centers.

The drug-coated balloons market research report is one of a series of new reports from The Business Research Company that provides drug-coated balloons market statistics, including drug-coated balloons industry global market size, regional shares, competitors with a drug-coated balloons market share, detailed drug-coated balloons market segments, market trends and opportunities, and any further data you may need to thrive in the drug-coated balloons industry. This drug-coated balloons market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug-coated balloons market size has grown rapidly in recent years. It will grow from $0.95 billion in 2023 to $1.1 billion in 2024 at a compound annual growth rate (CAGR) of 16.3%.The growth observed in the historical period can be ascribed to a heightened burden of cardiovascular diseases, a surge in the demand for minimally invasive procedures, the prevalence of peripheral artery disease (PAD), decreasing restenosis rates, and advancements in interventional cardiology.

The drug-coated balloons market size is expected to see rapid growth in the next few years. It will grow to $1.93 billion in 2028 at a compound annual growth rate (CAGR) of 15.0%. The anticipated growth in the forecast period can be credited to the rising aging population, the broadening of indications and applications, a focus on outpatient and ambulatory care, integration with innovations in drug delivery, and global health initiatives. Major trends expected in the forecast period encompass regulatory approvals for new formulations, a focus on minimizing side effects, the emergence of bioresorbable coatings, market expansion in emerging economies, and patient-centric approaches.

The anticipated rise in the prevalence of coronary artery disease is poised to drive the growth of the drug-coated balloons market. Coronary artery disease (CAD) is characterized by the narrowing or obstruction of the coronary arteries, which supply blood to the heart muscle, potentially leading to heart attacks. Drug-coated balloons are medical devices employed in the treatment of coronary artery disease, releasing medication into the artery during the procedure to mitigate the risk of restenosis, the re-narrowing of the artery post-angioplasty. For instance, a report by the Centers for Disease Control and Prevention in May 2023 revealed an increase in coronary heart disease deaths to 375,476 in the United States in 2021, with about 1 in 20 adults aged 20 and older diagnosed with coronary heart disease. Consequently, the upsurge in the prevalence of coronary artery disease is expected to bolster the drug-coated balloon market.

The increasing number of ambulatory surgery centers is anticipated to propel the growth of the drug-coated balloon market. Ambulatory Surgical Centers (ASCs) are medical facilities dedicated to conducting surgical procedures that do not necessitate an overnight hospital stay. Drug-coated balloons play a crucial role in ASCs by offering shorter procedure times compared to standard balloons, resulting in improved patient throughput and reduced operational costs. For instance, VMG Health reported in September 2023 that the total number of Medicare-certified ambulatory surgery centers increased by 2.9% from 1752 in 2021 to 1804 in 2022. Hence, the growing prevalence of ambulatory surgery centers is a driving force behind the drug-coated balloon market's expansion.

Product innovations represent a prominent trend gaining momentum in the drug-coated balloons market. Leading companies in the market are actively engaged in the development of new and innovative technological solutions to fortify their market position. An illustration of this trend is evident in Medtronic plc's introduction of the Prevail drug-coated balloon (DCB) Catheter in July 2021. This state-of-the-art tool is employed in percutaneous coronary intervention (PCI) procedures to address coronary artery disease (CAD) by delivering targeted therapy to blocked or constricted coronary arteries. Utilizing paclitaxel, a rapidly absorbable medication, this DCB enables effective treatment of various lesions, including in-stent restenosis (ISR), small vascular disease, and de novo lesions.

Major players in the drug-coated balloons market are strategically embracing collaboration and partnerships to enhance service delivery. A strategic partnership involves a structured affiliation between two or more commercial enterprises, typically established through business agreements or contracts. For example, in February 2021, Cardiovascular Systems Inc., a US-based provider of cardiovascular medical devices, entered into a partnership with Chansu Vascular Technologies LLC, a US-based manufacturer of peripheral and coronary DCBs. The collaboration aims to develop novel coronary and peripheral everolimus drug-coated balloons (DCBs) by leveraging CVT's proprietary drug-coating technology and CSI's expertise in balloon catheter design and manufacturing. This partnership aims to create next-generation DCBs that offer enhanced safety and efficacy for patients with peripheral artery disease (PAD) and coronary artery disease (CAD).

In November 2022, Cordis, a US-based manufacturer of interventional cardiovascular technologies, completed the acquisition of Med Alliance SA for $1.1 billion. Through this acquisition, Cordis aims to globally provide the drug-eluting balloon SELUTION SLRTM (Sustained Limus Release) to two million patients by 2027. Med Alliance SA, based in Switzerland, is a developer of the sirolimus micro-reservoir drug-coated balloon.

Major companies operating in the drug-coated balloons market report are Acotec Scientific AG, AR Baltic Medical AB, B. Braun Melsungen AG, Becton Dickinson and Company, Biosensors International Group Ltd., Medtronic Inc., Koninklijke Philips N.V, Boston Scientific Corporation, Opto Circuits, Acrostak Corp., BioMed, Concept Medical, Cardionovum GmbH, Endocor GmbH, Hexacath Sverige, iVascular SLU, Minvasys SAS, MedAlliance, QT Vascular Ltd., RD Global-Invamed, Terumo Corporation, Biotronik, Cook Medical, Cordis Corporation, Abbott Laboratories, Surmodics Inc., Hexacath SAS, MicroPort, SurModics Inc., Orchestra BioMed

North America was the largest region in the global drug-coated balloons market in 2023, and is expected to be the fastest-growing region in the forecast period. The regions covered in the drug-coated balloons market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the drug-coated balloons market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The drug-coated balloons market consists of sales of everolimus and zotarolimus drug-coated balloons. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r11690

1. Executive Summary

2. Drug-Coated Balloons Market Characteristics

3. Drug-Coated Balloons Market Trends And Strategies

4. Drug-Coated Balloons Market - Macro Economic Scenario

4.1. Impact Of High Inflation On the Market
4.2. Ukraine-Russia War Impact On the Market
4.3. COVID-19 Impact On the Market

5. Global Drug-Coated Balloons Market Size and Growth

5.1. Global Drug-Coated Balloons Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Drug-Coated Balloons Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Drug-Coated Balloons Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Drug-Coated Balloons Market Segmentation

6.1. Global Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Drug-Coated Balloons For Peripheral Artery Disease
Drug-Coated Balloons For Coronary Artery Disease
Drug-Coated Balloons For Other Indications
6.2. Global Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Paclitaxel
Sirolimus
6.3. Global Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Cardiac Catheterization Labs
Ambulatory Surgical Centers

7. Drug-Coated Balloons Market Regional And Country Analysis

7.1. Global Drug-Coated Balloons Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Drug-Coated Balloons Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Drug-Coated Balloons Market

8.1. Asia-Pacific Drug-Coated Balloons Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Drug-Coated Balloons Market

9.1. China Drug-Coated Balloons Market Overview
9.2. China Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Drug-Coated Balloons Market

10.1. India Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Drug-Coated Balloons Market

11.1. Japan Drug-Coated Balloons Market Overview
11.2. Japan Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Drug-Coated Balloons Market

12.1. Australia Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Drug-Coated Balloons Market

13.1. Indonesia Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Drug-Coated Balloons Market

14.1. South Korea Drug-Coated Balloons Market Overview
14.2. South Korea Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Drug-Coated Balloons Market

15.1. Western Europe Drug-Coated Balloons Market Overview
15.2. Western Europe Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Drug-Coated Balloons Market

16.1. UK Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Drug-Coated Balloons Market

17.1. Germany Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Drug-Coated Balloons Market

18.1. France Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Drug-Coated Balloons Market

19.1. Italy Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Drug-Coated Balloons Market

20.1. Spain Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Drug-Coated Balloons Market

21.1. Eastern Europe Drug-Coated Balloons Market Overview
21.2. Eastern Europe Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Drug-Coated Balloons Market

22.1. Russia Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Drug-Coated Balloons Market

23.1. North America Drug-Coated Balloons Market Overview
23.2. North America Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Drug-Coated Balloons Market

24.1. USA Drug-Coated Balloons Market Overview
24.2. USA Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Drug-Coated Balloons Market

25.1. Canada Drug-Coated Balloons Market Overview
25.2. Canada Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Drug-Coated Balloons Market

26.1. South America Drug-Coated Balloons Market Overview
26.2. South America Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Drug-Coated Balloons Market

27.1. Brazil Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Drug-Coated Balloons Market

28.1. Middle East Drug-Coated Balloons Market Overview
28.2. Middle East Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Drug-Coated Balloons Market

29.1. Africa Drug-Coated Balloons Market Overview
29.2. Africa Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Drug-Coated Balloons Market Competitive Landscape And Company Profiles

30.1. Drug-Coated Balloons Market Competitive Landscape
30.2. Drug-Coated Balloons Market Company Profiles
- 30.2.1. Acotec Scientific AG
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. AR Baltic Medical AB
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. B. Braun Melsungen AG
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Becton Dickinson and Company
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Biosensors International Group Ltd
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Global Drug-Coated Balloons Market Competitive Benchmarking

32. Global Drug-Coated Balloons Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Drug-Coated Balloons Market

34. Drug-Coated Balloons Market Future Outlook and Potential Analysis

34.1 Drug-Coated Balloons Market In 2028 - Countries Offering Most New Opportunities
34.2 Drug-Coated Balloons Market In 2028 - Segments Offering Most New Opportunities
34.3 Drug-Coated Balloons Market In 2028 - Growth Strategies
- 34.3.1 Market Trend Based Strategies
- 34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer